<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 14">
<meta name=Originator content="Microsoft Word 14">
<link rel=File-List href="fungsi_hati_files/filelist.xml">
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>fajar ramdhani</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Windows User</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>13</o:TotalTime>
  <o:Created>2017-08-05T02:49:00Z</o:Created>
  <o:LastSaved>2017-08-05T02:49:00Z</o:LastSaved>
  <o:Pages>6</o:Pages>
  <o:Words>1258</o:Words>
  <o:Characters>7173</o:Characters>
  <o:Lines>59</o:Lines>
  <o:Paragraphs>16</o:Paragraphs>
  <o:CharactersWithSpaces>8415</o:CharactersWithSpaces>
  <o:Version>14.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=themeData href="fungsi_hati_files/themedata.thmx">
<link rel=colorSchemeMapping href="fungsi_hati_files/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:SpellingState>Clean</w:SpellingState>
  <w:GrammarState>Clean</w:GrammarState>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>IN</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="267">
  <w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 9"/>
  <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" Priority="22" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536859905 -1073732485 9 0 511 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:IN;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:IN;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:IN;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:IN;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:IN;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-family:"Calibri","sans-serif";
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:IN;}
.MsoPapDefault
	{mso-style-type:export-only;
	margin-bottom:8.0pt;
	line-height:107%;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:1.0in 1.0in 1.0in 1.0in;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:25836893;
	mso-list-type:hybrid;
	mso-list-template-ids:-1843602948 -1354331782 69271555 69271557 69271553 69271555 69271557 69271553 69271555 69271557;}
@list l0:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:•;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;}
@list l0:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l0:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l0:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l0:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l0:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l0:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l0:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l0:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l1
	{mso-list-id:408384948;
	mso-list-type:hybrid;
	mso-list-template-ids:-1297976856 -1354331782 69271555 69271557 69271553 69271555 69271557 69271553 69271555 69271557;}
@list l1:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:•;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;}
@list l1:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l1:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l1:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l1:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l1:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l1:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l1:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l1:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l2
	{mso-list-id:752313970;
	mso-list-type:hybrid;
	mso-list-template-ids:-168153480 -1354331782 557613266 69271557 69271553 69271555 69271557 69271553 69271555 69271557;}
@list l2:level1
	{mso-level-start-at:4;
	mso-level-number-format:bullet;
	mso-level-text:•;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;}
@list l2:level2
	{mso-level-start-at:4;
	mso-level-number-format:bullet;
	mso-level-text:–;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;}
@list l2:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l2:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l2:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l2:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l2:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l2:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l2:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l3
	{mso-list-id:1016543813;
	mso-list-type:hybrid;
	mso-list-template-ids:1671616412 -1354331782 69271555 69271557 69271553 69271555 69271557 69271553 69271555 69271557;}
@list l3:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:•;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;}
@list l3:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l3:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l3:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l3:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l3:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l3:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l3:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l3:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l4
	{mso-list-id:1223754788;
	mso-list-type:hybrid;
	mso-list-template-ids:29160420 -1354331782 69271555 69271557 69271553 69271555 69271557 69271553 69271555 69271557;}
@list l4:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:•;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;}
@list l4:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l4:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l4:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l4:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l4:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l4:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l4:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l4:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l5
	{mso-list-id:1236160748;
	mso-list-type:hybrid;
	mso-list-template-ids:2016583292 -1354331782 69271555 69271557 69271553 69271555 69271557 69271553 69271555 69271557;}
@list l5:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:•;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;}
@list l5:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l5:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l5:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l5:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l5:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l5:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l5:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l5:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l6
	{mso-list-id:1358114770;
	mso-list-type:hybrid;
	mso-list-template-ids:1979339524 69271553 69271555 69271557 69271553 69271555 69271557 69271553 69271555 69271557;}
@list l6:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l6:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l6:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l6:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l6:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l6:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l6:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l6:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l6:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l7
	{mso-list-id:1504972685;
	mso-list-type:hybrid;
	mso-list-template-ids:-1457387076 -1354331782 69271555 69271557 69271553 69271555 69271557 69271553 69271555 69271557;}
@list l7:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:•;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;}
@list l7:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l7:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l7:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l7:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l7:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l7:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l7:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l7:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin-top:0in;
	mso-para-margin-right:0in;
	mso-para-margin-bottom:8.0pt;
	mso-para-margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:IN;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1026"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=WordSection1>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'>LABORATORIUM FUNGSI HATI<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>a)<span
style='mso-spacerun:yes'>  </span>Albumin<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'>Nilai Normal : 3,5 – 5,0 g% SI: 35-50g/L<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>Deskripsi:<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify;text-indent:.5in'><span lang=IN style='font-size:14.0pt;line-height:
107%;font-family:"Times New Roman","serif"'>Albumin di sintesa oleh hati dan
mempertahankan keseimbangan distribusi air dalam tubuh (tekanan onkotik
koloid). Albumin membantu transport beberapa komponen darah, seperti: ion,
bilirubin, hormon, enzim, obat. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>Implikasi
Klinis:<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoListParagraphCxSpFirst style='margin-bottom:0in;margin-bottom:.0001pt;
mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Nilai meningkat pada
keadaan dehidrasi<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpLast style='margin-bottom:0in;margin-bottom:.0001pt;
mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Nilai menurun pada
keadaan: malnutrisi, sindroma absorpsi, hipertiroid, kehamilan, gangguan fungsi
hati, infeksi kronik, luka bakar, edema, asites, sirosis, nefrotik sindrom,
SIADH, dan perdarahan.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>b)<span
style='mso-spacerun:yes'>  </span>Prothrombin Time <o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>Deskripsi :<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify;text-indent:.5in'><span lang=IN style='font-size:14.0pt;line-height:
107%;font-family:"Times New Roman","serif"'>untuk mengetahui kemampuan hati
dalam mensintesa faktor-faktor koagulasi (faktor I, II, V, VII, IX, X) kecuali
faktor VIII. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>c)<span
style='mso-spacerun:yes'>  </span>Alanin Aminotransferase (ALT) dahulu SGPT<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'>Nilai normal : 5-35 U/L <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>Deskripsi:<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify;text-indent:.5in'><span lang=IN style='font-size:14.0pt;line-height:
107%;font-family:"Times New Roman","serif"'>Konsentrasi enzim ALT yang tinggi
terdapat pada hati. ALT juga terdapat pada jantung, otot dan ginjal. ALT lebih
banyak terdapat dalam hati dibandingkan jaringan otot jantung dan lebih spesifi
k menunjukkan fungsi hati daripada AST. ALT berguna untuk diagnosa penyakit
hati dan memantau lamanya pengobatan penyakit hepatik, sirosis postneurotik dan
efek hepatotoksik obat. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>Implikasi
klinik:<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoListParagraphCxSpFirst style='margin-bottom:0in;margin-bottom:.0001pt;
mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Peningkatan kadar ALT
dapat terjadi pada penyakit hepatoseluler, sirosis aktif, obstruksi bilier dan
hepatitis. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0in;margin-bottom:
.0001pt;mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Banyak obat dapat
meningkatkan kadar ALT. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0in;margin-bottom:
.0001pt;mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Nilai peningkatan yang
signifi kan adalah dua kali lipat dari nilai normal. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpLast style='margin-bottom:0in;margin-bottom:.0001pt;
mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Nilai juga meningkat
pada keadaan: obesitas, preeklamsi berat, acute lymphoblastic leukemia (ALL)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt'><b
style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>d)<span
style='mso-spacerun:yes'>  </span>Aspartat Aminotransferase (AST) dahulu SGOT<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'>Nilai normal : 5 – 35 U/L <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>Deskripsi:<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify;text-indent:.5in'><span lang=IN style='font-size:14.0pt;line-height:
107%;font-family:"Times New Roman","serif"'>AST adalah enzim yang memiliki
aktivitas metabolisme yang tinggi, ditemukan di jantung, hati, otot rangka,
ginjal, otak, limfa, pankreas dan paru-paru. Penyakit yang menyebabkan
perubahan, kerusakan atau kematian sel pada jaringan tersebut akan
mengakibatkan terlepasnya enzim ini ke sirkulasi.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>Implikasi
klinik:<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoListParagraphCxSpFirst style='margin-bottom:0in;margin-bottom:.0001pt;
mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Peningkatan kadar AST
dapat terjadi pada MI, penyakit hati, pankreatitis akut, trauma, anemia hemolitik
akut, penyakit ginjal akut, luka bakar parah dan penggunaan berbagai obat,
misalnya: isoniazid, eritromisin, kontrasepsi oral <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0in;margin-bottom:
.0001pt;mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Penurunan kadar AST
dapat terjadi pada pasien asidosis dengan diabetes mellitus. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0in;margin-bottom:
.0001pt;mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Obat-obat yang
meningkatkan serum transaminase :<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:1.0in;margin-bottom:.0001pt;mso-add-space:auto;
text-align:justify;text-indent:-.25in;mso-list:l2 level2 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>–<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>Asetominofen<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:1.0in;margin-bottom:.0001pt;mso-add-space:auto;
text-align:justify;text-indent:-.25in;mso-list:l2 level2 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>–<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>Co-amoksiklav<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:1.0in;margin-bottom:.0001pt;mso-add-space:auto;
text-align:justify;text-indent:-.25in;mso-list:l2 level2 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>–<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>HMGCoA
reductase inhibitors<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:1.0in;margin-bottom:.0001pt;mso-add-space:auto;
text-align:justify;text-indent:-.25in;mso-list:l2 level2 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>–<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>INH<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:1.0in;margin-bottom:.0001pt;mso-add-space:auto;
text-align:justify;text-indent:-.25in;mso-list:l2 level2 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>–<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>Antiinfl
amasi nonsteroid<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:1.0in;margin-bottom:.0001pt;mso-add-space:auto;
text-align:justify;text-indent:-.25in;mso-list:l2 level2 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>–<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>Fenitoin<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpLast style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:1.0in;margin-bottom:.0001pt;mso-add-space:auto;
text-align:justify;text-indent:-.25in;mso-list:l2 level2 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>–<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>Valproat<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>e)<span
style='mso-spacerun:yes'>  </span>Gamma Glutamil transferase (GGT)<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'>Nilai normal :<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'>Laki-laki &#8804;94 U/L<span
style='mso-spacerun:yes'>  </span>SI : &#8804;1,5 &#956;kat/L<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'>Perempuan &#8804;70 U/L SI: &lt;1,12 &#956;kat/L<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>Deskripsi:<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify;text-indent:.5in'><span lang=IN style='font-size:14.0pt;line-height:
107%;font-family:"Times New Roman","serif"'>GGT terutama terdapat pada hati,
ginjal; terdapat dalam jumlah yang lebih rendah pada prostat, limfa, dan
jantung. Hati dianggap sebagai sumber enzim GGT meskipun kenyataannya kadar
enzim tertinggi terdapat di ginjal. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify;text-indent:.5in'><span lang=IN style='font-size:14.0pt;line-height:
107%;font-family:"Times New Roman","serif"'>Enzim ini merupakan marker
(penanda) spesifi k untuk fungsi hati dan kerusakan kolestatis dibandingkan
ALP. GGT adalah enzim yang diproduksi di saluran empedu sehingga meningkat
nilainya pada gangguan empedu <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify;text-indent:.5in'><span lang=IN style='font-size:14.0pt;line-height:
107%;font-family:"Times New Roman","serif"'>Enzim ini berfungsi dalam transfer
asam amino dan peptida. Laki-laki memiliki kadar yang lebih tinggi daripada
perempuan karena juga ditemukan pada prostat. Monitoring GGT berguna untuk
mendeteksi pecandu alkohol akut atau kronik, obstruksi jaundice, kolangitis dan
kolesistitis.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>Implikasi
klinik:<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoListParagraphCxSpFirst style='margin-bottom:0in;margin-bottom:.0001pt;
mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Peningkatan kadar GGT
dapat terjadi pada kolesistitis, koletiasis, sirosis, pankreatitis, atresia
billier, obstruksi bilier, penyakit ginjal kronis, diabetes mellitus,
pengggunaan barbiturat, obat-obat hepatotoksik (khususnya yang menginduksi
sistem P450). GGT sangat sensitif tetapi tidak spesifi k. Jika terjadi
peningkatan hanya kadar GGT (bukan AST, ALT) bukan menjadi indikasi kerusakan
hati. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpLast style='margin-bottom:0in;margin-bottom:.0001pt;
mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Obat-obat yang
menyebabkan peningkatan GGT antara lain karbamazepin, barbiturat, fenitoin,
serta obat yang menginduksi sistem sitokrom P450<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>f)<span
style='mso-spacerun:yes'>  </span>Alkalin Fosfatase (ALP)<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'>Nilai normal : 30 - 130 U/L <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>Deskripsi:<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify;text-indent:.5in'><span lang=IN style='font-size:14.0pt;line-height:
107%;font-family:"Times New Roman","serif"'>Enzim ini berasal terutama dari
tulang, hati dan plasenta. Konsentrasi tinggi dapat ditemukan dalam kanakuli
bilier, ginjal dan usus halus. Pelepasan enzim ini seperti juga indeks penyakit
tulang, terkait dengan produksi sel tulang dan deposisi kalsium pada tulang.
Pada penyakit hati kadar alkalin fosfatase darah akan meningkat karena
ekskresinya terganggu akibat obstruksi saluran bilier.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>Implikasi
Klinik:<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoListParagraphCxSpFirst style='margin-bottom:0in;margin-bottom:.0001pt;
mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Peningkatan ALP terjadi
karena faktor hati atau non-hati. Peningkatan ALP karena faktor hati terjadi
pada kondisi : obstruksi saluran empedu, kolangitis, sirosis, hepatitis
metastase, hepatitis, kolestasis, infi ltrating hati disease<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0in;margin-bottom:
.0001pt;mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Peningkatan ALP karena
faktor non-hati terjadi pada kondisi : penyakit tulang, kehamilan, penyakit
ginjal kronik, limfoma, beberapa malignancy, penyakit infl amasi/infeksi,
pertumbuhan tulang, penyakit jantung kongestif <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0in;margin-bottom:
.0001pt;mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Peningkatan kadar ALT
dapat terjadi pada obstruksi jaundice, lesi hati, sirosis hepatik, penyakit paget,
penyakit metastase tulang, osteomalasis, hiperparatiroidisme, infus nutrisi
parenteral dan hiperfosfatemia. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0in;margin-bottom:
.0001pt;mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Penurunan kadar ALT
dapat terjadi pada hipofosfatemia, malnutrisi dan hipotiroidisme. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpLast style='margin-bottom:0in;margin-bottom:.0001pt;
mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Setelah pemberian
albumin IV, seringkali terjadi peningkatan dalam jumlah sedang alkalin
fosfatase yang dapat berlangsung selama beberapa hari.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>g)<span
style='mso-spacerun:yes'>  </span>Bilirubin<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'>Nilai normal : <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'>Total &#8804; 1,4 mg/dL<span
style='mso-spacerun:yes'>  </span>SI = &lt;24 &#956;mmol/L<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'>Langsung &#8804; 0,40 mg/dL<span
style='mso-spacerun:yes'>  </span>SI = &lt;7 &#956;mmol/L<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>Deskripsi:<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify;text-indent:.5in'><span lang=IN style='font-size:14.0pt;line-height:
107%;font-family:"Times New Roman","serif"'>Bilirubin terjadi dari hasil
peruraian hemoglobin dan merupakan produk antara dalam proses hemolisis.
Bilirubin dimetabolisme oleh hati dan diekskresi ke dalam empedu sedangkan
sejumlah kecil ditemukan dalam serum. Peningkatan bilirubin terjadi jika
terdapat pemecahan sel darah merah berlebihan atau jika hati tidak dapat
mensekresikan bilirubin yang dihasilkan.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'>Terdapat dua bentuk bilirubin:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify'><span lang=IN
style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>a)<span
style='mso-spacerun:yes'>  </span>tidak langsung atau tidak terkonjugasi
(terikat dengan protein).<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify'><span lang=IN
style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>b)<span
style='mso-spacerun:yes'>  </span>langsung atau terkonjugasi yang terdapat
dalam serum.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'>Peningkatan kadar bilirubin terkonjugasi lebih
sering terjadi akibat peningkatan<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'>pemecahan eritrosit, sedangkan peningkatan bilirubin
tidak terkonjugasi lebih<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'>cenderung akibat disfungsi atau gangguan fungsi
hati.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>Implikasi
klinik:<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoListParagraphCxSpFirst style='margin-bottom:0in;margin-bottom:.0001pt;
mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Peningkatan bilirubin
yang disertai penyakit hati dapat terjadi pada gangguan hepatoseluler, penyakit
sel parenkim, obstruksi saluran empedu atau hemolisis sel darah merah.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0in;margin-bottom:
.0001pt;mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Peningkatan kadar
bilirubin tidak terkonjugasi dapat terjadi pada anemia hemolitik, trauma
disertai dengan pembesaran hematoma dan infark pulmonal.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0in;margin-bottom:
.0001pt;mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Bilirubin terkonjugasi
tidak akan meningkat sampai dengan penurunan fungsi hati hingga 50% <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0in;margin-bottom:
.0001pt;mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Peningkatan kadar
bilirubin terkonjugasi dapat terjadi pada kanker pankreas dan kolelitiasis <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0in;margin-bottom:
.0001pt;mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Peningkatan kadar
keduanya dapat terjadi pada metastase hepatik, hepatitis, sirosis dan
kolestasis akibat obat – obatan. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0in;margin-bottom:
.0001pt;mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Pemecahan bilirubin
dapat menyamarkan peningkatan bilirubin. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0in;margin-bottom:
.0001pt;mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Obat-obat yang dapat
meningkatkan bilirubin: obat yang bersifat hepatotoksik dan efek kolestatik,
antimalaria (primakuin, sulfa, streptomisin, rifampisin, teofi lin, asam
askorbat, epinefrin, dekstran, metildopa) <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpLast style='margin-bottom:0in;margin-bottom:.0001pt;
mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Obat-obat yang
meningkatkan serum bilirubin dan ALP : Allopurinol,<span
style='mso-spacerun:yes'>  </span>karbamazepin,<span style='mso-spacerun:yes'> 
</span>kaptopril,<span style='mso-spacerun:yes'>  </span>klorpropamid,<span
style='mso-spacerun:yes'>  </span>siproheptadin, diltiazem, eritromisin,
co-amoxiclav, estrogen, nevirapin, quinidin, TMP- SMZ<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>h)<span
style='mso-spacerun:yes'>  </span>Laktat dihidrogenase (dahulu LDH)<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'>Nilai normal : 90-210 U/L SI : 1,5-3,5 &#956;kat/L<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>Deskripsi<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify;text-indent:.5in'><span lang=IN style='font-size:14.0pt;line-height:
107%;font-family:"Times New Roman","serif"'>LD merupakan enzim intraseluler, LD
terdistribusi secara luas dalam jaringan, terutama hati, ginjal, jantung, paru-paru,
otot rangka. Enzim glikolitik ini mengkatalisasi perubahan laktat dan piruvat.
LD bersifat non spesifik, tetapi membantu menegakkan diagnosis infark miokard
atau infark pulmonal bersamaan dengan data klinik lain. LD juga sangat
bermanfaat dalam mendiagnosa distropi otot atau anemia pernisiosa. Penentuan
yang lebih spesifik dapat dilakukan jika LD telah terurai menjadi isoenzim.
Oleh karena itu isoenzim spesifi k diperlukan untuk mendeteksi infark miokard.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify;text-indent:.5in'><span lang=IN style='font-size:14.0pt;line-height:
107%;font-family:"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span lang=IN style='font-size:
14.0pt;line-height:107%;font-family:"Times New Roman","serif"'>Implikasi klinik<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span lang=IN style='font-size:14.0pt;line-height:107%;font-family:
"Times New Roman","serif"'><o:p>&nbsp;</o:p></span></p>

<p class=MsoListParagraphCxSpFirst style='margin-bottom:0in;margin-bottom:.0001pt;
mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Pada MI akut, LD meningkat
dengan perbandingan LD1 : LD2 &gt; 1, kadar meningkat dalam 12-24 jam infark
dan puncaknya terjadi 3-4 hari setelah infark miokard.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0in;margin-bottom:
.0001pt;mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Pada infark pulmonal,
LD meningkat dalam 24 jam setelah onset nyeri. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0in;margin-bottom:
.0001pt;mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Peningkatan kadar LD
dapat terjadi pada infark miokard akut, leukemia akut, nekrosis otot rangka,
infark pulmonal, kelainan kulit, syok, anemia megalobastik dan limfoma.
Penggunaan bermacam obat-obatan dan status penyakit juga dapat meningkatkan
kadar LD. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpLast style='margin-bottom:0in;margin-bottom:.0001pt;
mso-add-space:auto;text-align:justify;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
lang=IN style='font-size:14.0pt;line-height:107%;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>•<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=IN style='font-size:14.0pt;
line-height:107%;font-family:"Times New Roman","serif"'>Penurunan kadar LD
menggambarkan respon yang baik terhadap terapi kanker.<o:p></o:p></span></p>

</div>

</body>

</html>
